Currently, several clinical trials are ongoing which aim to explore the treatment of anemia in patients with chronic kidney disease and cancer patients receiving chemotherapy using Peginesatide, a functional analog of erythropoietin [59]. The gene discussed is EPO; the disease is anemia.